“DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY”. 2026. International Research Journal of Pharmacy 17 (3): 1-11. https://doi.org/10.56802/e8qzhp89.